{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:52:20Z","timestamp":1761173540837,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.purol.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T07:23:02Z","timestamp":1435908182000},"page":"616-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Surveillance des carcinomes uroth\u00e9liaux\u00a0: revue du Comit\u00e9 de canc\u00e9rologie de l\u2019Association fran\u00e7aise d\u2019urologie"],"prefix":"10.1016","volume":"25","author":[{"given":"P.","family":"Colin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Neuzillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pignot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Comperat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Larr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Quintens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Houed\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Souli\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00330-007-0792-x","article-title":"CT urography: definition, indications and techniques. A guideline for clinical practice","volume":"18","author":"Van Der Molen","year":"2008","journal-title":"Eur Radiol"},{"issue":"Suppl. 2","key":"10.1016\/j.purol.2015.05.012_bib0010","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S1166-7087(13)70049-6","article-title":"Recommandations 2013 du CCAFU\u00a0: cancer de vessie","volume":"23","author":"Pfister","year":"2013","journal-title":"Prog Urol"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0015","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2214\/AJR.08.1318","article-title":"Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract","volume":"192","author":"Vikram","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.purol.2015.05.012_bib0020","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1007\/s00330-007-0609-y","article-title":"Multidetector-row computed tomography (MDCT) in patients with a history of previous urothelial cancer or painless macroscopic haematuria","volume":"17","author":"Mueller-Lisse","year":"2007","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.purol.2015.05.012_bib0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejrad.2008.10.026","article-title":"Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis","volume":"73","author":"Chlapoutakis","year":"2008","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0030","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2214\/ajr.184.6.01841873","article-title":"MDCT urography of upper tract urothelial neoplasms","volume":"184","author":"Caoili","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00261-008-9360-3","article-title":"Detection of upper tract urothelial neoplasms: sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography","volume":"33","author":"Dillman","year":"2008","journal-title":"Abdom Imaging"},{"issue":"4","key":"10.1016\/j.purol.2015.05.012_bib0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrurol.2012.32","article-title":"CT urography for hematuria","volume":"9","author":"Cowan","year":"2012","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00261-008-9418-2","article-title":"Transitional cell carcinoma of upper urinary tract vs. benign lesions: distinctive MSCT features","volume":"34","author":"Wang","year":"2009","journal-title":"Abdom Imaging"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0050","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s00330-005-0078-0","article-title":"Multiphasic multidetector-row CT (MDCT) in detection and staging of transitional cell carcinomas of the upper urinary tract","volume":"16","author":"Fritz","year":"2006","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.purol.2015.05.012_bib0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"Hovels","year":"2008","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.purol.2015.05.012_bib0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiol.2472070798","article-title":"Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography","volume":"247","author":"Takahashi","year":"2008","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S1677-55382010000100004","article-title":"Diffusion weighted imaging in the detection of upper urinary tract urothelial tumors","volume":"36","author":"Nishizawa","year":"2010","journal-title":"Int Braz J Urol"},{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00345-012-0945-7","article-title":"Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI","volume":"31","author":"Sufana Iancu","year":"2013","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1148\/radiol.2511080873","article-title":"Urinary bladder cancer: diffusion-weighted MR imaging\u00a0\u2013\u00a0accuracy for diagnosing T stage and estimating histologic grade","volume":"251","author":"Takeuchi","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0080","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.ijrobp.2011.11.065","article-title":"Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer","volume":"83","author":"Yoshida","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.purol.2015.05.012_bib0085","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1464-410X.2010.09212.x","article-title":"Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma","volume":"106","author":"Lodde","year":"2010","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.purol.2015.05.012_bib0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00259-012-2294-6","article-title":"Diuretic 18F-FDG PET\/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique","volume":"40","author":"Nayak","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.purol.2015.05.012_bib0095","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.juro.2012.11.009","article-title":"FDG-positron emission tomography\/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer","volume":"189","author":"Mertens","year":"2013","journal-title":"J Urol"},{"issue":"6\u00a0Suppl. 1","key":"10.1016\/j.purol.2015.05.012_bib0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2005.08.064","article-title":"Bladder tumor markers beyond cytology: internationalconsensus panel on bladder tumor markers","volume":"66","author":"Lokeshwar","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.purol.2015.05.012_bib0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0302-2838(02)00006-4","article-title":"Differences between local and review urinary cytology and diagnosis of bladder cancer. An interobserver multicenter analysis","volume":"41","author":"Raitanen","year":"2002","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.eururo.2005.03.014","article-title":"Urine markers for bladder cancer surveillance: a systematic review","volume":"47","author":"van Rhijn","year":"2005","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2015.05.012_bib0115","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1\u00a0bladder cancer using EORTC risk tables: a combined analysis of 2596\u00a0patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2015.05.012_bib0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2011.05.033","article-title":"The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: external validation of the EORTC risk tables","volume":"60","author":"Fernandez-Gomez","year":"2011","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2015.05.012_bib0125","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.juro.2012.09.084","article-title":"Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance","volume":"189","author":"Linton","year":"2013","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2015.05.012_bib0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2012.05.008","article-title":"Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature","volume":"62","author":"Soukup","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1464-410X.2007.06841.x","article-title":"Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments","volume":"100","author":"Sanderson","year":"2007","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0140","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.juro.2009.08.046","article-title":"Upper urinary tract recurrence after radical cystectomy for bladder cancer\u00a0\u2013\u00a0who is at risk?","volume":"182","author":"Volkmer","year":"2009","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0145","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.juro.2012.08.017","article-title":"Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185\u00a0patients","volume":"188","author":"Picozzi","year":"2012","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00345-012-0905-2","article-title":"Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols","volume":"31","author":"Perlis","year":"2013","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0155","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.eururo.2011.08.030","article-title":"Risk factors and outcomes of urethral recurrence following radical cystectomy","volume":"60","author":"Boorjian","year":"2011","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2015.05.012_bib0160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000019550","article-title":"Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy","volume":"33","author":"Lebret","year":"1998","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2015.05.012_bib0165","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.eururo.2007.06.045","article-title":"Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729\u00a0male patients","volume":"53","author":"Huguet","year":"2008","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.purol.2015.05.012_bib0170","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0022-5347(01)65462-4","article-title":"Urethral recurrence in patients with orthotopic ileal neobladders","volume":"156","author":"Freeman","year":"1996","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2015.05.012_bib0175","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0360-3016(93)90306-G","article-title":"Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12","volume":"25","author":"Tester","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.purol.2015.05.012_bib0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.urolonc.2006.09.015","article-title":"Long-term outcome of radiation-based conservation therapy for invasive bladder cancer","volume":"25","author":"Chung","year":"2007","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0185","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1464-410X.2004.05034.x","article-title":"Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer","volume":"94","author":"Nieuwenhuijzen","year":"2004","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.purol.2015.05.012_bib0190","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2214\/AJR.08.1430","article-title":"staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?","volume":"192","author":"Watanabe","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.purol.2015.05.012_bib0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3747\/co.v16i4.411","article-title":"Conservative treatment of invasive bladder cancer","volume":"16","author":"Rene","year":"2009","journal-title":"Curr Oncol"},{"issue":"6\u00a0Suppl. 4","key":"10.1016\/j.purol.2015.05.012_bib0200","first-page":"S237","article-title":"Surveillance strategies after definitive therapy of invasive bladder cancer","volume":"3","author":"Cagiannos","year":"2009","journal-title":"Can Urol Assoc J"},{"issue":"5","key":"10.1016\/j.purol.2015.05.012_bib0205","first-page":"1135","article-title":"[Post-therapeutic surveillance of infiltrating tumors of the bladder]","volume":"12","author":"Zerbib","year":"2002","journal-title":"Prog Urol"},{"issue":"Suppl. 2","key":"10.1016\/j.purol.2015.05.012_bib0210","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/S1166-7087(13)70050-2","article-title":"Recommandations 2013 du CCAFU\u00a0: tumeurs des voies excr\u00e9trices sup\u00e9rieures","volume":"23","author":"Pfister","year":"2013","journal-title":"Prog Urol"},{"issue":"11","key":"10.1016\/j.purol.2015.05.012_bib0215","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1464-410X.2008.07438.x","article-title":"Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract","volume":"101","author":"Novara","year":"2008","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2012.08.010","article-title":"Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma","volume":"32","author":"Pignot","year":"2014","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.purol.2015.05.012_bib0225","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","article-title":"Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2015.05.012_bib0230","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.eururo.2011.05.049","article-title":"Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy","volume":"60","author":"Ouzzane","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2015.05.012_bib0235","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/cncr.20395","article-title":"Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome","volume":"101","author":"Holmang","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.purol.2015.05.012_bib0240","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","article-title":"Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review","volume":"110","author":"Cutress","year":"2012","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.purol.2015.05.012_bib0245","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.eururo.2012.01.010","article-title":"EAU guidelines on laser technologies","volume":"61","author":"Herrmann","year":"2012","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2015.05.012_bib0250","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2012.10.020","article-title":"Conservative management of upper tract urothelial carcinoma in France: a 2004\u20132011\u00a0national practice report","volume":"63","author":"Colin","year":"2013","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.purol.2015.05.012_bib0255","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1464-410X.2012.10960.x","article-title":"Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study","volume":"110","author":"Colin","year":"2012","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.purol.2015.05.012_bib0260","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.juro.2009.12.018","article-title":"Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter","volume":"183","author":"Jeldres","year":"2010","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2015.05.012_bib0265","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.urolonc.2010.07.010","article-title":"Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma","volume":"30","author":"Fritsche","year":"2012","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.purol.2015.05.012_bib0270","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2015.05.012_bib0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.juro.2010.03.030","article-title":"Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma","volume":"184","author":"Brien","year":"2010","journal-title":"J Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S116670871500189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S116670871500189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:26:46Z","timestamp":1761114406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S116670871500189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S116670871500189X"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2015.05.012","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance des carcinomes uroth\u00e9liaux\u00a0: revue du Comit\u00e9 de canc\u00e9rologie de l\u2019Association fran\u00e7aise d\u2019urologie","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}